• Field Trial Evaluation of Liquichek Serum Indices for Pre-analytical Monitoring L. Wong, H. Onishi, M. Gonzales
• Evaluating the Components of Risk of Patient Harm from Erroneous Results J. C. Yundt-Pacheco

At the completion of the presentation, the audience will be able to:

• Describe two QC strategies for multiple instruments and the advantage of each.
• Explain why instrument performance is not enough when determining QC frequency and identify a 2nd criterion.
• Identify the number of data points and criteria needed for a reduced crossover study based on the latest version of CLSI C24.

Ann Gronowski, PhD
Assoc. Medical Director, Clin Chem, Serology, & Immunology
Barnes-Jewish Hospital
📹 Watch Introduction | 📹 Watch Q&A Session

Curtis Parvin, PhD
Biostatistical Advisor
Bio-Rad Laboratories
Considerations When Looking at QC for Multiple Instruments
📹 Watch Presentation | 📃 Download Presentation

John Yundt-Pacheco, MSCS
Scientific Fellow
Bio-Rad Laboratories
Beyond Sigma Metrics
📹 Watch Presentation | 📃 Download Presentation

Nico Vandepoele, BSc
Scientific/Professional Affairs Manager
Bio-Rad Laboratories
Crossover Studies
📹 Watch Presentation | 📃 Download Presentation